Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia.
Agathocleous A, Rohatiner A, Rule S, Hunter H, Kerr JP, Neeson SM, Matthews J, Strauss S, Montoto S, Johnson P, Radford J, Lister A. Agathocleous A, et al. Among authors: rohatiner a. Br J Haematol. 2010 Nov;151(4):346-53. doi: 10.1111/j.1365-2141.2010.08340.x. Epub 2010 Sep 29. Br J Haematol. 2010. PMID: 20880120 Free article. Clinical Trial.
Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity.
Strauss SJ, Maharaj L, Hoare S, Johnson PW, Radford JA, Vinnecombe S, Millard L, Rohatiner A, Boral A, Trehu E, Schenkein D, Balkwill F, Joel SP, Lister TA. Strauss SJ, et al. Among authors: rohatiner a. J Clin Oncol. 2006 May 1;24(13):2105-12. doi: 10.1200/JCO.2005.04.6789. Epub 2006 Apr 10. J Clin Oncol. 2006. PMID: 16606971 Clinical Trial.
Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy.
Intermesoli T, Shamash J, Rohatiner A, Wilson A, Lister A, Montoto S. Intermesoli T, et al. Among authors: rohatiner a. Br J Haematol. 2009 Nov;147(3):408-10. doi: 10.1111/j.1365-2141.2009.07847.x. Epub 2009 Aug 2. Br J Haematol. 2009. PMID: 19664002 Free article. Clinical Trial. No abstract available.
Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia - very long follow-up.
Rohatiner AZ, Smith ML, Spinelli O, Rambaldi A, Bassan R, di Bona E, Rodeghiero F, Raimondi R, Björkholm M, Johnson S, Newland AC, Cavenagh JD, Macdougall F, Waters R, Fitzgibbon J, Barbui T, Lister A. Rohatiner AZ, et al. Br J Haematol. 2014 Dec;167(5):724-6. doi: 10.1111/bjh.13055. Epub 2014 Jul 29. Br J Haematol. 2014. PMID: 25074579 Free article. No abstract available.
178 results